We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+24.4%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.78B
AUM Growth
-$224M
(-11%)
Cap. Flow
-$162M
Cap. Flow
% of AUM
-9.08%
Top 10 Holdings %
Top 10 Hldgs %
64.26%
Holding
62
New
5
Increased
1
Reduced
29
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celcuity
CELC
|
+$12.8M |
| 2 |
X4 Pharmaceuticals
XFOR
|
+$8.23M |
| 3 |
Acrivon Therapeutics
ACRV
|
+$6.11M |
| 4 |
MIMO.WS.C
Airspan Networks Holdings Inc Warrants
MIMO.WS.C
|
+$671K |
| 5 |
MIMO.WS.B
Airspan Networks Holdings Inc Warrants
MIMO.WS.B
|
+$663K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IonQ
IONQ
|
+$56.6M |
| 2 |
ACLX
Arcellx
ACLX
|
+$46M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$32.5M |
| 4 |
AKUS
Akouos Inc
AKUS
|
+$29.1M |
| 5 |
IVA
Inventiva
IVA
|
+$19.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 71.35% |
| 2 | Consumer Staples | 10.55% |
| 3 | Technology | 10.5% |
| 4 | Industrials | 7.01% |
| 5 | Communication Services | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Coursera
COUR
$1.74B
| $188M | 10.55% |
15,867,769
| – | – |
|
|
ACLX
2
DELISTED
Arcellx
ACLX
| $147M | 8.26% |
4,745,262
-2,005,002
| -30% | -$46M |
|
|
VRNA
3
DELISTED
Verona Pharma
VRNA
| $146M | 8.2% |
5,584,753
| – | – |
|
4
Rhythm Pharmaceuticals
RYTM
$7.36B
| $143M | 8.03% |
4,909,956
-2,350
| -0% | -$60.4K |
|
|
NEUE
5
DELISTED
NeueHealth
NEUE
| $142M | 7.97% |
2,726,920
-732
| -0% | -$53.2K |
|
6
Cloudflare
NET
$94.2B
| $84.7M | 4.76% |
1,873,823
-3,687
| -0.2% | -$182K |
|
7
Mirum Pharmaceuticals
MIRM
$6.67B
| $81.6M | 4.59% |
4,186,243
-1,558
| -0% | -$30.8K |
|
|
ZFOX
8
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $81M | 4.55% |
18,068,513
-22,348
| -0.1% | -$104K |
|
|
OYST
9
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $66.2M | 3.72% |
5,925,287
| – | – |
|
10
CRISPR Therapeutics
CRSP
$4.65B
| $64.5M | 3.63% |
1,587,854
-2,148
| -0.1% | -$114K |
|
11
Monte Rosa Therapeutics
GLUE
$1.85B
| $58.5M | 3.29% |
7,692,298
-10,907
| -0.1% | -$90.9K |
|
|
ALLK
12
DELISTED
Allakos
ALLK
| $51.8M | 2.91% |
6,147,260
-1,444
| -0% | -$10K |
|
|
13
IonQ
IONQ
$12.2B
| $50.4M | 2.83% |
14,614,829
-11,735,238
| -45% | -$56.6M |
|
14
CVRx
CVRX
$133M
| $43.5M | 2.44% |
2,370,542
-316
| -0% | -$3.9K |
|
15
Geron
GERN
$917M
| $39.5M | 2.22% |
16,318,681
| – | – |
|
16
Savara
SVRA
$1.08B
| $37.4M | 2.1% |
24,137,931
| – | – |
|
|
CBIO
17
Crescent Biopharma
CBIO
$586M
| $27.2M | 1.53% |
89,677
-1,213
| -1% | -$179K |
|
|
ADAP
18
DELISTED
Adaptimmune Therapeutics
ADAP
| $24.9M | 1.4% |
17,079,779
-2,833
| -0% | -$4.59K |
|
19
NextNav
NN
$1.78B
| $24M | 1.35% |
8,189,156
| – | – |
|
|
BGRY
20
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $23.1M | 1.3% |
38,183,023
-43,598
| -0.1% | -$48.7K |
|
|
CTIC
21
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $22.2M | 1.24% |
3,685,683
| – | – |
|
22
Trevi Therapeutics
TRVI
$2.54B
| $22M | 1.23% |
11,373,174
| – | – |
|
23
Nkarta
NKTX
$155M
| $21.4M | 1.2% |
3,568,781
-2,859
| -0.1% | -$28.9K |
|
|
DM
24
DELISTED
Desktop Metal, Inc.
DM
| $19.6M | 1.1% |
1,439,893
-866
| -0.1% | -$18.1K |
|
|
25
Celcuity
CELC
$3.92B
| $17.5M | 0.98% |
+1,250,001
| New | +$12.8M |
|
Similar funds
NM
SLF
CCIA
SW
CGH
PWP
CIP
KOCAA
NEA Management Company's Q4 2022 Portfolio in Review
As of Q4 2022, NEA Management Company held 62 positions worth $1.78B, down 11% from $2B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
NEA Management Company withdrew a net $162M in Q4 2022, closing 5 positions and reducing 29 holdings. Its most notable exit was AVEO Pharmaceuticals, Inc., an estimated $32.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 67% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, NEA Management Company opened a new position in Celcuity worth $17.5M.
- NEA Management Company's largest Q4 2022 buy was Celcuity: 1,250,001 shares worth $17.5M.
- NEA Management Company added most to X4 Pharmaceuticals in Q4 2022, an estimated $8.23M increase.
- NEA Management Company's biggest Q4 2022 reduction was IonQ, cutting an estimated $56.6M.
- NEA Management Company fully exited AVEO Pharmaceuticals, Inc. in Q4 2022, selling an estimated $32.5M.
- NEA Management Company's ten largest holdings make up 64% of its $1.78B portfolio in Q4 2022.
- NEA Management Company opened 5 new positions and closed 5 in Q4 2022.
- NEA Management Company's portfolio value fell 11% quarter-over-quarter to $1.78B.
Based on NEA Management Company's 13F filing for Q4 2022, filed 10 Feb 2023.